Evidence map›Paper›PMID 38744813›Full record

ArticleNature communications2024

Functional and antigenic characterization of SARS-CoV-2 spike fusion peptide by deep mutational scanning.

Ruipeng Lei, Enya Qing, Abby Odle, Meng Yuan, Chaminda D Gunawardene, Timothy J C Tan, Natalie So, Wenhao O Ouyang, Ian A Wilson, Tom Gallagher and 3 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. TMPRSS2-mediated coronavirus spike activation and inhibition.Nature structural & molecular biology · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Structural Immunology of SARS-CoV-2.Immunological reviews · 2025
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Ruipeng Lei *Department of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, IL, 61801, USA.ORCID http://orcid.org/0000-0002-4652-3400
Enya Qing *Department of Microbiology and Immunology, Loyola University Chicago, Maywood, IL, 60153, USA.ORCID http://orcid.org/0000-0002-7455-3463
Abby OdleDepartment of Microbiology and Immunology, University of Iowa, Iowa City, IA, 52242, USA.
Meng YuanDepartment of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, 92037, USA.ORCID http://orcid.org/0000-0001-9754-4503
Chaminda D GunawardeneCenter for Virus-Host Innate Immunity, Rutgers New Jersey Medical School, Newark, NJ, 07103, USA.
Timothy J C TanCenter for Biophysics and Quantitative Biology, University of Illinois at Urbana-Champaign, Urbana, IL, 61801, USA.ORCID http://orcid.org/0000-0001-5337-5357
Natalie SoDepartment of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, IL, 61801, USA.
Wenhao O OuyangDepartment of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, IL, 61801, USA.
Ian A WilsonDepartment of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, 92037, USA.ORCID http://orcid.org/0000-0002-6469-2419
Tom GallagherDepartment of Microbiology and Immunology, Loyola University Chicago, Maywood, IL, 60153, USA. tgallag@luc.edu.ORCID http://orcid.org/0000-0002-8601-5961
Stanley PerlmanDepartment of Microbiology and Immunology, University of Iowa, Iowa City, IA, 52242, USA. stanley-perlman@uiowa.edu.ORCID http://orcid.org/0000-0003-4213-2354
Nicholas C WuDepartment of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, IL, 61801, USA. nicwu@illinois.edu.ORCID http://orcid.org/0000-0002-9078-6697
Lok-Yin Roy WongDepartment of Microbiology and Immunology, University of Iowa, Iowa City, IA, 52242, USA. roy.wong@rutgers.edu.ORCID http://orcid.org/0000-0002-0727-8289

Funding

SARS-CoV Proteins in Heterologous Viral InfectionP01AI060699 · NIAID · UNIVERSITY OF IOWA · PI PERLMAN, STANLEY · 2004 to 2021
$21.5M
Role of eicosanoids in pathogenic human CoV infectionsR01AI129269 · NIAID · UNIVERSITY OF IOWA · PI Stanley Perlman · 2016 to 2026
$4.7M
Phenotypic and functional characterization of Betacoronavirus Internal protein in relation to virulenceR00AI170996 · NIAID · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI WONG, LOK-YIN ROY · 2024 to 2025
$498k
Impacts of Adaptive Coronavirus Evolution on Viral Membrane FusionR21AI178391 · NIAID · LOYOLA UNIVERSITY CHICAGO · PI GALLAGHER, THOMAS MILLER · 2023 to 2024
$437k
NIAID NIH HHS P01 AI060699NIAID NIH HHS R00 AI170996NIAID NIH HHS R01 AI129269NIAID NIH HHS R21 AI178391
6 · The paper itself

Abstract

The fusion peptide of SARS-CoV-2 spike protein is functionally important for membrane fusion during virus entry and is part of a broadly neutralizing epitope. However, sequence determinants at the fusion peptide and its adjacent regions for pathogenicity and antigenicity remain elusive. In this study, we perform a series of deep mutational scanning (DMS) experiments on an S2 region spanning the fusion peptide of authentic SARS-CoV-2 in different cell lines and in the presence of broadly neutralizing antibodies. We identify mutations at residue 813 of the spike protein that reduced TMPRSS2-mediated entry with decreased virulence. In addition, we show that an F823Y mutation, present in bat betacoronavirus HKU9 spike protein, confers resistance to broadly neutralizing antibodies. Our findings provide mechanistic insights into SARS-CoV-2 pathogenicity and also highlight a potential challenge in developing broadly protective S2-based coronavirus vaccines.

Indexed as

Antibodies, NeutralizingCOVID-19MutationSARS-CoV-2Spike Glycoprotein, CoronavirusVirus InternalizationAnimalsAntibodies, ViralCell LineChlorocebus aethiopsEpitopesHEK293 CellsHumansMiceSerine EndopeptidasesVero CellsAntibodies, NeutralizingAntibodies, ViralEpitopesSerine EndopeptidasesSpike Glycoprotein, Coronavirus

Identifiers

PMID38744813
PMCPMC11094058

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.